4.6 Article

Enzymatic redesigning of biologically active heparan sulfate

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 280, Issue 52, Pages 42817-42825

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M504338200

Keywords

-

Funding

  1. NHLBI NIH HHS [HL52622, R01 HL052622, R01 HL062244-05A1, R01 HL062244] Funding Source: Medline
  2. NIAID NIH HHS [AI50050, R01 AI050050] Funding Source: Medline
  3. NIGMS NIH HHS [GM069968, R01 GM038060, R01 GM038060-16A2, GM38060, R01 GM069968, R01 GM038060-17] Funding Source: Medline

Ask authors/readers for more resources

Heparan sulfate carries a wide range of biological activities, regulating blood coagulation, cell differentiation, and inflammatory responses. The sulfation patterns of the polysaccharide are essential for the biological activities. In this study, we report an enzymatic method for the sulfation of multimilligram amounts of heparan sulfate with specific functions using immobilized sulfotransferases combined with a 3'-phosphoadenosine 5'-phosphosulfate regeneration system. By selecting appropriate enzymatic modification steps, an inactive precursor has been converted to the heparan sulfate having three distinct biological activities, associated with binding to antithrombin, fibroblast growth factor-2, and herpes simplex virus envelope glycoprotein D. Because the recombinant sulfotransferases are expressed in bacteria, and the method uses a low cost sulfo donor, it can be readily utilized to synthesize large quantities of anticoagulant heparin drug or other biologically active heparan sulfates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available